Inducible nitric oxide production and expression of transforming growth factor-β1 in serum and CSF after cerebral ischaemic stroke in man

Nitric Oxide - Biology and Chemistry

Volumn 2, Issue 6, 1998, Pages 442-453

  Krupinski, Jerzy ^a,b   Vodovotz, Yoram ^c   Li, Cheng Gang ^d   Slowik, Agnieszka ^a   Beevers, Dory ^e   Flanders, Kathleen C ^e   Lip, Greg ^f   Kumar, Pat ^b   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Nitric oxide; Stroke; TGF 1

Indexed keywords

NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTE; BLOOD LEVEL; BRAIN ISCHEMIA; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MALE; MICROVASCULATURE; NERVE CELL; PRIORITY JOURNAL; STROKE;

EID: 0032409607     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1998.0204     Document Type: Article

References (62)

1. Astrup J., Siesjo B., Lindsay S. Thresholds in cerebral ischaemia - The ischaemic penumbra. Stroke. 6:1981;723-725.
2. Iadecola C. Regulation of the cerebral microcirculation during neural activity: Is nitric oxide the missing link? Trends. Neurosci. 16:1993;206-214.
3. Kimura M., Dietrich H., Dacey R. Nitric oxide regulates cerebral arteriolar tone in rats. Stroke. 25:1994;2227-2233.
4. Moncada S. The 1991 Ulf von Euler Lecture: TheL. Acta Physiol. Scand. 145:1992;201-227.
5. Zhang J., Snyder S. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:1995;213-233.
6. Radomski M., Palmer R., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA. 87:1990;10043-10047.
7. Nakashima M., Yamashita K., Kataoka Y., Yamashita Y., Sniwa M. Time course of nitric oxide synthase activity in neuronal, glial, and endothelial cells of rat striatum following focal cerebral ischemia. Cell. Mol. Neurobiol. 15:1995;341-349.
8. Minc-Golomb D., Tsarfaty I., Schwartz J. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br. J. Pharmacol. 112:1994;720-722.
9. Iadecola C., Zhang F., Xu S., Casey R., Ross M. Inducible nitric oxide synthase gene expression in brain following cerebral ischaemia. J. Cereb. Blood Flow Metab. 15:1995;378-384.
10. Wink D., Grisham M., Mitchell J., Ford P. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol. 268:1996;12-31.
11. Nicotera P., Bonfoco E., Brüne B. Mechanisms for nitric oxide-induced cell death: Involvement of apoptosis. Adv. Neuroimmunol. 5:1995;411-420.
12. Dimmeler S., Zeiher A. M. Nitric oxide and apotosis: Another paradigm for the double-edged role of nitric oxide. Nitric Oxide Biol. Chem. 1:1997;275-281.
13. Nathan C., Xie Q. Nitric oxide synthases: Roles, tolls, and controls. Cell. 78:1994;915-918.
14. Ding A., Nathan C., Graycar J., Derynek R., Stuehr D., Srimal S. Macrophage deactivating factor and transforming growth factors- 1, -2, and -3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 145:1994;940-944.
15. Heck D., Laskin D., Gardner C., Laskin J. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes: Potential role for nitric oxide in the regulation of wound healing. J. Biol. Chem. 267:1992;21277-21280.
16. Goureau O., Lepoivre M., Becquet F., Courtois Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: Inverse correlation with cellular proliferation. Proc. Natl. Acad. Sci. USA. 90:1993;4276-4280.
17. Vodovotz Y., Bogdan C., Paik J., Xie Q., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178:1993;605-613.
18. Vodovotz Y. Control of nitric oxide production by transforming growth factor-β1: Mechanistic insights and potential relevance to human disease. Nitric Oxide Biol. Chem. 1:1997;3-17.
19. Vodovotz Y., Geiser A. G., Chesler L., Letterio J. J., Campbell A., Lucia M. S., Sporn M. B., Roberts A. B. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor-β1 null mouse. J. Exp. Med. 183:1996;2337-2342.
20. Finch C. E., Laping N. J., Morgan T. E., Nichols N. R., Pasinetti G. M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53:1993;314-322.
21. Kriegelstein K., Ruffer M., Suter-Crazzolara C., Unsicker K. Neural functions of the transforming growth factors β Int. J. Dev. Neurosci. 13:1995;301-315.
22. Krupinski J., Kumar P., Kumar S., Kaluza J. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke. 27:1996;852-857.
23. Flanders K., Lippa C., Smith T., Pollen D., Sporn M. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology. 45:1995;1561-1569.
24. Lippa C. F., Smith T. W., Flanders K. C. Transforming growth factor-β: Neuronal and glial expression in CNS degenerative diseases. Neurodeg. 4:1995;425-432.
25. Vodovotz Y., Lucia M., Flanders K., Chesler L., Xie Q., Smith T., Weinder J., Mumford R., Webber R., Nathan C., Roberts A., Lippa C., Sporn M. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1996;1425-1434.
26. Dorheim M., Tracey W., Pollack J., Gramms P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:1994;659-665.
27. Nicholson S., da Gloria Bonecini-Almeida M., Lapa e Silva J. R., Nathan C., Xie Q. W., Mumford R., Weidner J., Calaycay J., Geng J., Boechat N., Linhares C., Rom W., Ho J. L. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:1996;2293-2302.
28. Danielpour D., Kim K., Dart L., Watanabe S., Roberts A., Sporn M. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF beta 2) in complex biological fluids. Growth Factors. 2:1989;61-71.
29. Blann A., Wang M., Wilson P., Kumar S. Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis. 120:1996;221-226.
30. Wong M. L., Rettori V., al-Shekhlee A., Bongiorni P. B., Canteros G., McCann S. M., Gold P. W., Licinio J. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 2:1996;581-584.
31. Bo L., Dawson T., Wesselingh S., Mork S., Choi S., Kong P., Hanley D., Trapp B. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
32. Bagasra O., Michaels F., Zheng Y., Bobroski L., Spitsin S., Fu Z., Tawardos R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 19:1995;12041-12045.
33. Brorson J., Marcuccilli C., Miller R. Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke. 26:1995;1259-1266.
34. Bukrinsky M., Nottet H. Regulation of nitric oxide synthase in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745.
35. Eke A., Conger K., Anderson M., Garcia J. Histologic assessment of neurons in rat models of cerebral ischemia. Stroke. 21:1990;299-304.
36. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
37. Dinerman J. L., Dawson T. M., Schell M. J., Snowman A., Snyder S. H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA. 91:1994;4214-4218.
38. Szaflarski J., Burtrum D., Silverstein F. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke. 26:1995;1093-1100.
39. Wang Z., Alm P., Hakanson R. The contribution of nitric oxide to endotoxin-induced ocular inflammation: Interaction with sensory nerve fibres. Br. J. Pharmacol. 118:1996;1537-1543.
40. Boje K., Arora P. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
41. Merrill J., Ignarro L., Sherman M., Melinek J., Lane T. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1992;2132-2141.
42. Endoh M., Maiese K., Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 651:1994;92-100.
43. Faraci F., Breese K., Heistad D. Cerebral vasodilatation during hypercapnia: Role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke. 25:1994;1679-1683.
44. Flaumenhaft R., Abe M., Sato Y., Miyazono K., Harpel J., Heldin C., Rifkin D. Role of the altent TGF-beta binding protein in the activation of latent TGF-beta co-cultures of endothelial and smooth muscle cells. J. Cell. Biol. 120:1994;995-1002.
45. McCartney-Francis N., Wahl S. Transforming growth factor beta: A matter of life and death. J. Leukocyte Biol. 55:1994;401-409.
46. Peress N., Perillo E. Differential expression of TGF-beta 1, 2, and 3 isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54:1995;802-811.
47. Gross C., Bednar M., Howard D., Sporn M. Transforming growth factor beta1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke. 24:1993;558-562.
48. Gross C., Howard D., Dooley R., Raymond S., Fuller S., Bednar M. TGF-beta1 post-treatment in a rabbit model of cerebral ischaemia. Neurol. Res. 16:1994;465-470.
49. Wang X., Yue T., White R., Barone F., Feurstein G. Transforming growth factor beta-1 exhibits delayed gene expression following focal cerebral ischaemia. Brain Res. 36:1995;607-609.
50. Flaumenhaft R., Kojima S., Abe M., Rifkin D. B. Activation of latent transforming growth factor β Adv. Pharmacol. 24:1993;51-76.
51. Barcellos-Hoff M. H., Ehrhart E. J., Kalia M., Jirtle R., Flanders K., Tsang M. L. S. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am. J. Pathol. 147:1995;1228-1237.
52. Milstien S., Sakai N., Brew B. J., Krieger C., Vickers J. H., Saito K., Heyes M. P. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J. Neurochem. 63:1994;1178-1180.
53. Molina J. A., Jiménez-Jiménez F. J., Vavarro J. A., Ruiz E., Arenas J., Cabrera-Valdivia F., Vázquez A., Fernández-Calle P., Ayuso-Peralta L., Rabasa M., Bermejo F. Plasma levels of nitrates in patients with Parkinson's disease. J. Neurol. Sci. 127:1994;87-89.
54. Gilbert R., Herschman H. Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem. Biophys. Res. Commun. 195:1993;380-384.
55. Knowles R., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
56. Huang Z., Huang P., Panahian N., Dalkara T., Fishman M., Moskowitz M. Effects of cerebral ischaemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
57. Lefer A., Ma X., Weyrich A., Scalia R. Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc. Natl. Acad. Sci. USA. 90:1993;1018-1022.
58. Inoue N., Venema R., Sayegh H., Ohara Y., Murphy T., Harrison D. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor beta 1. Arterioscler. Thromb. Vasc. Biol. 15:1995;1255-1261.
59. Yoshida T., Limmorth V., Irikura K., Moskowitz M. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
60. Faraci F., Brian J. Nitric oxide and the cerebral circulation. Stroke. 25:1994;692-703.
61. Sancesario G., Iannone M., Morello M., Nistico G., Bernardi G. Nitric oxide inhibition aggravates ischaemic damage of hippocampal but not of NADPH Neurons in gerbils. Stroke. 25:1994;436-444.
62. Hyman B., Marzloff K., Wenninger J., Dawson T., Bredt D., Snyder S. Relative sparing of nitric oxide synthase-containing neurones in the hippocampal formation in Alzheimer's disease. Ann. Neurol. 32:1992;818-820.